Barron Partners Encourages the Board of Directors of Computer Software Innovations Inc. to Accept Constellation's Tender Offer and to Revoke the Poison Pill

News provided by

Apr 09, 2012, 11:01 ET

NEW YORK, April 9, 2012 /PRNewswire/ -- Barron Partners LP's CEO, Andrew Barron Worden, today stated: "After years of poor performance for shareholders, the announcement of the tender offer by Constellation Software Inc. has finally caused an increase in value for the shareholders of Computer Software Innovations Inc. ("CSWI"). Barron Partners has previously notified the board of directors of CSWI that we strongly support the Constellation tender offer. In the letter we urged the board to act in the interests of the shareholders and to accept the Constellation tender offer. In addition, Barron Partners has previously advised the board of directors that we believe the rights offering (poison pill) should be revoked, since we believe that it is in direct violation of the Preferred Stock Purchase Agreement dated as of February 10, 2005 by and between CSI and Barron and in direct violation of the Amended and Restated Certificate of Designation of Preferences, Rights and Limitations of the Series A Convertible Preferred Stock of CSI dated November 7, 2005."

Barron Partners LP is an international private investment fund with a primary focus on profitable cleantech companies. Barron has invested over $450 million of its capital since its formation in 2002. For more information about Barron Partners, visit www.barronpartners.com

SOURCE Barron Partners